InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Aktis Oncology, Inc.

AKTS
United States Fiscal year ends December CIK 0002035832 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Akos Czibere
23 Sep 2026
Chief Medical Officer
Sold after exercise
7,401
$21.03
$155.65K
Akos Czibere
23 Sep 2026
Chief Medical Officer
Sold after exercise
5,099
$20.19
$102.97K
Ken Herrmann
20 Jul 2026
Director
Sold after exercise
1,350
$24.56
$33.16K
Ken Herrmann
20 Jul 2026
Director
Sold after exercise
3,506
$24.56
$86.12K
Ken Herrmann
17 Jul 2026
Director
Sold after exercise
3,065
$25.21
$77.26K
Akos Czibere
8 Jul 2026
Chief Medical Officer
Sold after exercise
4,371
$28.71
$125.48K
Akos Czibere
8 Jul 2026
Chief Medical Officer
Sold after exercise
30,829
$27.95
$861.74K
Akos Czibere
8 Jul 2026
Chief Medical Officer
Sold after exercise
14,800
$27.13
$401.48K
Shulamit Ron-Bigger
8 Jul 2026
Chief Operating Officer
Sold after exercise
4,200
$28.75
$120.74K
Shulamit Ron-Bigger
8 Jul 2026
Chief Operating Officer
Sold after exercise
30,000
$27.94
$838.14K
Shulamit Ron-Bigger
8 Jul 2026
Chief Operating Officer
Sold after exercise
15,800
$27.13
$428.68K
Show all 20 transactions →

What was left out

Form 4 filings counted 13
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 11
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 34,344,412
History held since 12 Jan 2026